125 related articles for article (PubMed ID: 23271265)
1. Association of myeloproliferative and lymphoproliferative disorders.
Gaillard JB; Carillo S; Henry L; Jourdan E; Lavabre-Bertrand T
Clin Adv Hematol Oncol; 2012 Nov; 10(11):756-7. PubMed ID: 23271265
[No Abstract] [Full Text] [Related]
2. Liver biopsy diagnosis of unsuspected or unconfirmed lymphoproliferative or myeloproliferative disorders.
Ludwig J; Boon SE
Hepatogastroenterology; 1980 Feb; 27(1):17-25. PubMed ID: 7203353
[TBL] [Abstract][Full Text] [Related]
3. Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations.
Papageorgiou A; Ziakas PD; Tzioufas AG; Voulgarelis M
Clin Exp Rheumatol; 2013; 31(1):76-83. PubMed ID: 23010147
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance imaging (MRI) of the spleen and bone marrow in hematology].
Kurdziel JC; Dondelinger RF; Dicato MA; Ries F; Primo H; Freilinger J
J Belge Radiol; 1988; 71(2):211-29. PubMed ID: 3170468
[No Abstract] [Full Text] [Related]
5. Lymphoproliferative and myeloproliferative disorders.
Savage CJ
Vet Clin North Am Equine Pract; 1998 Dec; 14(3):563-78, vii. PubMed ID: 9891725
[TBL] [Abstract][Full Text] [Related]
6. [Experience of twenty years in modern nomenclature of myeloproliferative and lymphoproliferative diseases].
Werner W
Zentralbl Allg Pathol; 1982; 126(5-6):473-5. PubMed ID: 7158101
[No Abstract] [Full Text] [Related]
7. The occurrence of HBV infection in polytransfused patients with haematologic malignancies.
Casaril M; Perini A; Gabrielli GB; Miatto O; Celebrano R; Gasparini G; Corrocher R
Haematologica; 1980 Jun; 65(3):309-16. PubMed ID: 6778782
[No Abstract] [Full Text] [Related]
8. [Concurrent lymphoproliferative and myeloproliferative disorders in three patients].
Hernández Sánchez MC; García Quiroga H; Ulibarrena Redondo C; Méndez Sánchez JA
An Med Interna; 2008 Feb; 25(2):78-80. PubMed ID: 18432364
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of sarcoidosis and malignant disease: causality or coincidence?
Brincker H
Sarcoidosis; 1989 Mar; 6(1):31-43. PubMed ID: 2657921
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of lymphoproliferative diseases by bone marrow trepanobiopsy specimens].
Frank GA; Kaplanskaia IB; Glasko EN; Semenov EA; Roshchina LS; Korolev AV
Arkh Patol; 2007; 69(3):15-8. PubMed ID: 17722588
[TBL] [Abstract][Full Text] [Related]
11. Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy.
Louis ED; Hanley AE; Brannagan TH; Sherman W; Murphy P; Lange DJ; Trojaborg W; Younger DS; Lovelace RE; Latov N; Rowland LP
Muscle Nerve; 1996 Oct; 19(10):1334-7. PubMed ID: 8808660
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders.
Federici AB; Rand JH; Mannucci PM
Hematol J; 2001; 2(6):358-62. PubMed ID: 11920274
[No Abstract] [Full Text] [Related]
13. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases.
Dührsen U; Augener W; Zwingers T; Brittinger G
Br J Haematol; 1987 Oct; 67(2):235-9. PubMed ID: 3499930
[TBL] [Abstract][Full Text] [Related]
14. Sequential occurrence of chronic lymphocytic leukemia and refractory anemia with erythroblastic dysplasia and PAS positivity.
Woessner S; Lafuente R; Sans-Sabrafen J; Pardo P; Florensa L
Acta Haematol; 1983; 69(3):204-7. PubMed ID: 6404106
[No Abstract] [Full Text] [Related]
15. Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disorders.
Kesteven PJ; Pullan JM; Glass UH; Wetherley-Mein G
Clin Lab Haematol; 1985; 7(4):297-306. PubMed ID: 3830529
[TBL] [Abstract][Full Text] [Related]
16. [Critical states in hemoblastoses (their typical forms and survival in a resuscitation department)].
Vorob'ev AI; Gorelov VG; Gorodetskiĭ VM; Shulutko EM
Ter Arkh; 1993; 65(7):3-6. PubMed ID: 8211775
[No Abstract] [Full Text] [Related]
17. Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations.
Dubois A; Dauzat M; Pignodel C; Pomier-Layrargues G; Marty-Double C; Lopez FM; Janbon C
Hepatology; 1993 Feb; 17(2):246-50. PubMed ID: 8428721
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
19. Myelofibrosis in myeloproliferative disorders.
Srinivasan U; Talvalkar GV; Advani SH
Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
[No Abstract] [Full Text] [Related]
20. Myeloproliferative and lymphoproliferative disorders in the same patient.
Iland H; Chan W; Vincent PC
Aust N Z J Med; 1980 Dec; 10(6):650-3. PubMed ID: 6938186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
